{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:40:36Z","timestamp":1793292036147,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.sleep.2024.10.037","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T04:48:12Z","timestamp":1730350092000},"page":"618-626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Samelisant (SUVN-G3031), a histamine 3 receptor inverse agonist: Results from the phase 2 double-blind randomized placebo-controlled study for the treatment of excessive daytime sleepiness in adult patients with narcolepsy"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2045-0784","authenticated-orcid":false,"given":"Ramakrishna","family":"Nirogi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod Kumar","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyothsna","family":"Ravula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Benade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Jetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh Kumar","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramkumar","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veera Raghava","family":"Chowdary Palacharla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Rasheed","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renny","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanunjay Kumar","family":"Dogiparti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilayaraja","family":"Kalaikadhiban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Jayarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkat","family":"Jasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Bogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.sleep.2024.10.037_bib1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41582-019-0226-9","article-title":"Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment","volume":"15","author":"Bassetti","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1016\/j.sleep.2024.10.037_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/ana.10444","article-title":"The neurobiology, diagnosis, and treatment of narcolepsy","volume":"53","author":"Scammell","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.sleep.2024.10.037_bib3","article-title":"Narcolepsy and rapid eye movement sleep","volume":"2","author":"Biscarini","year":"2024","journal-title":"J Sleep Res"},{"key":"10.1016\/j.sleep.2024.10.037_bib4","article-title":"Narcolepsy","volume":"3","author":"Kornum","year":"2017","journal-title":"Nat Rev Dis Prim"},{"issue":"12","key":"10.1016\/j.sleep.2024.10.037_bib5","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1080\/14656566.2021.1915987","article-title":"How treatable is narcolepsy with current pharmacotherapy and what does the future hold?","volume":"22","author":"Pellitteri","year":"2021","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.sleep.2024.10.037_bib6","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419875622","article-title":"Recent advances in treatment for narcolepsy","volume":"12","author":"Barateau","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"10.1016\/j.sleep.2024.10.037_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5935\/1984-0063.20170004","article-title":"Current and future treatment options for narcolepsy: a review","volume":"10","author":"Bhattarai","year":"2017","journal-title":"Sleep Sci"},{"issue":"5","key":"10.1016\/j.sleep.2024.10.037_bib8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s40263-016-0337-4","article-title":"Treatment options for narcolepsy","volume":"30","author":"Barateau","year":"2016","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.sleep.2024.10.037_bib9","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/17460441.2024.2354293","article-title":"Hits and misses with animal models of narcolepsy and the implications for drug discovery","volume":"19","author":"Nirogi","year":"2024","journal-title":"Expet Opin Drug Discov"},{"issue":"9","key":"10.1016\/j.sleep.2024.10.037_bib10","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1111\/ene.14888","article-title":"European guideline and expert statements on the management of narcolepsy in adults and children","volume":"28","author":"Bassetti","year":"2021","journal-title":"Eur J Neurol"},{"issue":"9","key":"10.1016\/j.sleep.2024.10.037_bib11","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.5664\/jcsm.9328","article-title":"Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline","volume":"17","author":"Maski","year":"2021","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleep.2024.10.037_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.14150","article-title":"Eating disorders in narcolepsy type 1: evidence from a cross-sectional Italian study","author":"Baldini","year":"2024","journal-title":"J Sleep Res"},{"issue":"1","key":"10.1016\/j.sleep.2024.10.037_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/brainsci13010043","article-title":"Psychotic episode and schizophrenia in slovakian narcolepsy database","volume":"13","author":"Feketeov\u00e1","year":"2022","journal-title":"Brain Sci"},{"issue":"20","key":"10.1016\/j.sleep.2024.10.037_bib14","doi-asserted-by":"crossref","first-page":"e2755","DOI":"10.1212\/WNL.0000000000010737","article-title":"Depression and suicidal thoughts in untreated and treated narcolepsy: systematic analysis","volume":"95","author":"Barateau","year":"2020","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.sleep.2024.10.037_bib15","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/oby.2003.156","article-title":"Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity","volume":"11","author":"Kok","year":"2003","journal-title":"Obes Res"},{"issue":"6","key":"10.1016\/j.sleep.2024.10.037_bib16","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.sleep.2013.03.002","article-title":"Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population","volume":"14","author":"Ohayon","year":"2013","journal-title":"Sleep Med"},{"issue":"1","key":"10.1016\/j.sleep.2024.10.037_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.smrv.2010.06.004","article-title":"Histamine in the regulation of wakefulness","volume":"15","author":"Thakkar","year":"2011","journal-title":"Sleep Med Rev"},{"issue":"4","key":"10.1016\/j.sleep.2024.10.037_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1620\/tjem.195.197","article-title":"Studies on functional roles of the histaminergic neuron system by using pharmacological agents, knockout mice and positron emission tomography","volume":"195","author":"Watanabe","year":"2001","journal-title":"Tohoku J Exp Med"},{"issue":"5","key":"10.1016\/j.sleep.2024.10.037_bib19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/smrv.2000.0116","article-title":"Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons","volume":"4","author":"Lin","year":"2000","journal-title":"Sleep Med Rev"},{"issue":"2","key":"10.1016\/j.sleep.2024.10.037_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-4328(01)00222-4","article-title":"Modifying effects of histamine on circadian rhythms and neuronal excitability","volume":"124","author":"Tuomisto","year":"2001","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.sleep.2024.10.037_bib21","first-page":"62","article-title":"Essentials of sleep neuropharmacology","author":"Bianchi","year":"2011","journal-title":"Therapy in Sleep Medicine"},{"issue":"4","key":"10.1016\/j.sleep.2024.10.037_bib22","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/bph.15220","article-title":"Histaminergic neurons in the tuberomammillary nucleus as a control centre for wakefulness","volume":"178","author":"Yoshikawa","year":"2021","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.sleep.2024.10.037_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsy183","article-title":"Histamine: neural circuits and new medications","volume":"42","author":"Scammell","year":"2019","journal-title":"Sleep"},{"issue":"6","key":"10.1016\/j.sleep.2024.10.037_bib24","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/bjp.2008.147","article-title":"The histamine H3 receptor: an attractive target for the treatment of cognitive disorders","volume":"154","author":"Esbenshade","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.sleep.2024.10.037_bib25","unstructured":"Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/211150s005s006lbl.pdf (accessed 11-July-2024)."},{"key":"10.1016\/j.sleep.2024.10.037_bib26","unstructured":"Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/ozawade-epar-product-information_en.pdf (accessed 5-October-2024)."},{"issue":"3","key":"10.1016\/j.sleep.2024.10.037_bib27","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1021\/acs.jmedchem.8b01280","article-title":"Discovery and development of N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide dihydrochloride (SUVN-G3031): a novel, potent, selective, and orally active histamine H3 receptor inverse agonist with robust wake-promoting activity","volume":"62","author":"Nirogi","year":"2019","journal-title":"J Med Chem"},{"issue":"6","key":"10.1016\/j.sleep.2024.10.037_bib28","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00213-021-05779-x","article-title":"Samelisant (SUVN-G3031), a potent, selective and orally active histamine H3 receptor inverse agonist for the potential treatment of narcolepsy: pharmacological and neurochemical characterisation","volume":"238","author":"Nirogi","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.sleep.2024.10.037_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105425","article-title":"Absorption, distribution, metabolism, excretion (ADME), drug-drug interaction potential and prediction of human pharmacokinetics of SUVN-G3031, a novel histamine 3 receptor (H3R) inverse agonist in clinical development for the treatment of narcolepsy","volume":"152","author":"Nirogi","year":"2020","journal-title":"Eur J Pharmaceut Sci"},{"issue":"7","key":"10.1016\/j.sleep.2024.10.037_bib30","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s40261-020-00920-8","article-title":"Safety, tolerability, and pharmacokinetics of SUVN-G3031, a novel histamine-3 receptor inverse agonist for the treatment of narcolepsy, in healthy human subjects following single and multiple oral doses","volume":"40","author":"Nirogi","year":"2020","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.sleep.2024.10.037_bib31","unstructured":"Available from: http:\/\/clinicaltrials.gov;Identifier:NCT04072380 (accessed 11-July-2024)."},{"issue":"8","key":"10.1016\/j.sleep.2024.10.037_bib32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4155\/bio-2020-0020","article-title":"LC-MS\/MS method for the quantification of SUVN-G3031, a novel H3 receptor inverse agonist for narcolepsy treatment","volume":"12","author":"Nirogi","year":"2020","journal-title":"Bioanalysis"},{"issue":"1","key":"10.1016\/j.sleep.2024.10.037_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12888-022-03785-7","article-title":"Optimal dose determination of enerisant (TS-091) for patients with narcolepsy: two randomized, double-blind, placebo-controlled trials","volume":"22","author":"Inoue","year":"2022","journal-title":"BMC Psychiatr"},{"key":"10.1016\/j.sleep.2024.10.037_bib34","article-title":"Correlation between the Epworth sleepiness scale and the maintenance of wakefulness test in obstructive sleep apnea patients treated with positive airway pressure","volume":"78","author":"Basille","year":"2020","journal-title":"Respir Med Res"},{"issue":"3","key":"10.1016\/j.sleep.2024.10.037_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13210","article-title":"Relationship between sleep efficacy endpoints and measures of functional status and health-related quality of life in participants with narcolepsy or obstructive sleep apnea treated for excessive daytime sleepiness","volume":"30","author":"Weaver","year":"2021","journal-title":"J Sleep Res"},{"issue":"12","key":"10.1016\/j.sleep.2024.10.037_bib36","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/S1388-2457(99)00167-4","article-title":"Subjective sleepiness ratings (Epworth sleepiness scale) do not reflect the same parameter of sleepiness as objective sleepiness (maintenance of wakefulness test) in patients with narcolepsy","volume":"110","author":"Sangal","year":"1999","journal-title":"Clin Neurophysiol"},{"issue":"4","key":"10.1016\/j.sleep.2024.10.037_bib37","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.smrv.2013.08.002","article-title":"Evaluation of the measurement properties of the Epworth sleepiness scale: a systematic review","volume":"18","author":"Kendzerska","year":"2014","journal-title":"Sleep Med Rev"},{"issue":"10","key":"10.1016\/j.sleep.2024.10.037_bib38","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.sleep.2013.04.010","article-title":"Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study","volume":"14","author":"Herring","year":"2013","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2024.10.037_bib39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.sleep.2023.07.008","article-title":"Epworth sleepiness scale: a meta-analytic study on the internal consistency","volume":"109","author":"Gon\u00e7alves","year":"2023","journal-title":"Sleep Med"},{"issue":"7","key":"10.1016\/j.sleep.2024.10.037_bib40","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.5665\/sleep.4810","article-title":"Comparing treatment effect measurements in narcolepsy: the sustained attention to response task, Epworth sleepiness scale and maintenance of wakefulness test","volume":"38","author":"van der Heide","year":"2015","journal-title":"Sleep"},{"issue":"9","key":"10.1016\/j.sleep.2024.10.037_bib41","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.5664\/jcsm.9326","article-title":"Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment","volume":"17","author":"Maski","year":"2021","journal-title":"J Clin Sleep Med"},{"issue":"11","key":"10.1016\/j.sleep.2024.10.037_bib42","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S1474-4422(13)70225-4","article-title":"Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial","volume":"12","author":"Dauvilliers","year":"2013","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.sleep.2024.10.037_bib43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ana.25423","article-title":"A randomized study of solriamfetol for excessive sleepiness in narcolepsy","volume":"85","author":"Thorpy","year":"2019","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.sleep.2024.10.037_bib44","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1212\/WNL.54.5.1166","article-title":"Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy","volume":"54","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.sleep.2024.10.037_bib45","first-page":"42","article-title":"A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy","volume":"25","year":"2002","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.sleep.2024.10.037_bib46","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5664\/jcsm.26368","article-title":"A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy","volume":"1","year":"2005","journal-title":"J Clin Sleep Med"},{"issue":"6","key":"10.1016\/j.sleep.2024.10.037_bib47","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsab200","article-title":"Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy","volume":"45","author":"Kushida","year":"2022","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.sleep.2024.10.037_bib48","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1474-4422(16)30333-7","article-title":"Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial","volume":"16","author":"Szakacs","year":"2017","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.sleep.2024.10.037_bib49","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2007.12.003","article-title":"An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-\/- mice and patients","volume":"30","author":"Lin","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.sleep.2024.10.037_bib50","unstructured":"Available from: http:\/\/clinicaltrials.gov;Identifier:NCT00366080 (accessed 11-July-2024)."},{"key":"10.1016\/j.sleep.2024.10.037_bib51","unstructured":"Available from: http:\/\/clinicaltrials.gov;Identifier:NCT03194217 (accessed 11-July-2024)."},{"issue":"11","key":"10.1016\/j.sleep.2024.10.037_bib52","doi-asserted-by":"crossref","first-page":"zsz174","DOI":"10.1093\/sleep\/zsz174","article-title":"Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study","volume":"42","author":"Dauvilliers","year":"2019","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.sleep.2024.10.037_bib53","article-title":"pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy","volume":"10","author":"Sarfraz","year":"2022","journal-title":"Health Psychol Res"},{"key":"10.1016\/j.sleep.2024.10.037_bib54","series-title":"Oral contraceptive pills. [Updated 2024 feb 29]. In: StatPearls [internet]","author":"Cooper","year":"2024"},{"key":"10.1016\/j.sleep.2024.10.037_bib55","series-title":"Narcolepsy. [Updated 2023 jun 12]. In: StatPearls [internet]","author":"Slowik","year":"2024"},{"issue":"8","key":"10.1016\/j.sleep.2024.10.037_bib56","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.5664\/jcsm.8482","article-title":"Prevalence of narcolepsy and other sleep disorders and frequency of diagnostic tests from 2013-2016 in insured patients actively seeking care","volume":"16","author":"Acquavella","year":"2020","journal-title":"J Clin Sleep Med"},{"issue":"7","key":"10.1016\/j.sleep.2024.10.037_bib57","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsz091","article-title":"Prevalence and incidence of narcolepsy in a US health care claims database, 2008-2010","volume":"42","author":"Scheer","year":"2019","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.sleep.2024.10.037_bib58","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaa206","article-title":"Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy","volume":"44","author":"Bogan","year":"2021","journal-title":"Sleep"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945724005033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945724005033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T04:20:03Z","timestamp":1737778803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945724005033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":58,"alternative-id":["S1389945724005033"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2024.10.037","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Samelisant (SUVN-G3031), a histamine 3 receptor inverse agonist: Results from the phase 2 double-blind randomized placebo-controlled study for the treatment of excessive daytime sleepiness in adult patients with narcolepsy","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2024.10.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}